Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.
about
Nonmuscle Tissues Contribution to Cancer CachexiaCancer as a Proinflammatory Environment: Metastasis and CachexiaUnderstanding cachexia as a cancer metabolism syndromeSources and Functions of Extracellular Small RNAs in Human Circulation.Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis.Current status of interleukin-10 and regulatory T-cells in cancerGut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target.Liver inflammation and metabolic signaling in ApcMin/+ mice: the role of cachexia progression.Sex differences in the relationship of IL-6 signaling to cancer cachexia progressionThe effect of exercise on IL-6-induced cachexia in the Apc ( Min/+) mouse.Differential Bone Loss in Mouse Models of Colon Cancer Cachexia.Circulating Biomarkers of Gut Barrier Function: Correlates and Nonresponse to Calcium Supplementation among Colon Adenoma Patients.Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas.Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexiaThe emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation.High-fat Diet Accelerates Intestinal Tumorigenesis Through Disrupting Intestinal Cell Membrane Integrity.Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia.Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia.Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.Role of interleukin-6 in cachexia: therapeutic implications.Developing models for cachexia and their implications in drug discovery.Obesity and cancer: inflammation bridges the two.Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis.High-Fat Diet-Induced Complement Activation Mediates Intestinal Inflammation and Neoplasia, Independent of Obesity.Dietary feeding of freeze-dried whole cranberry inhibits intestinal tumor development in Apcmin/+ mice.Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus.Ovarian function's role during cancer cachexia progression in the female mouse.The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression.Dietary Fiber Treatment Corrects the Composition of Gut Microbiota, Promotes SCFA Production, and Suppresses Colon Carcinogenesis.Increased gut permeability in cancer cachexia: mechanisms and clinical relevance.
P2860
Q26777562-34F7A402-DFBD-4E85-A10F-2B8435201B2CQ26778324-9727DE85-34F9-4BF0-8597-B9709B9485FFQ28069390-49FB3F56-684A-4353-A0CD-0EBF62280C25Q33822089-75DBC504-71FD-45E0-9D8A-442BBC96F2D6Q33928256-FA7E9AEB-86EF-45C5-886A-5F952B625C08Q34374026-C3D8965B-453C-46B4-ADB0-0073429DE5CCQ35025946-40E686FA-2D27-4D99-90AA-6B74DD7D622CQ35196068-AB9063D3-9D65-45EF-A30C-2FF72B2907AEQ35214154-E4811F1C-360A-47A5-BE32-299CCA877BA3Q36028206-B3F37075-0620-447A-AC56-21C7CA62572DQ36260536-2891E630-CEA7-442B-9E73-552E06320248Q36619670-0E6B5FA1-5A24-444E-89B6-81F175103EEAQ36688889-79BCB717-8BFA-4265-8DD1-FAEC9F4C5098Q36737744-87884E3F-1814-4875-90CA-CCC99EC9AADCQ36901945-888F8C41-2662-4CF9-86E5-6636EBE4D78DQ36918817-90564180-BE4E-464D-94F4-C04AD0322CD1Q37066421-3FED0DDC-45F5-4F2C-B1A8-B5742E447038Q37268163-E11A08B0-09EE-4706-B7E6-C9A0297217CAQ37392800-433203F5-7F10-440D-91C4-FEF465C7C611Q37503704-7A060D66-C446-4349-9A69-978B7296782DQ38260561-DD6907E0-AF68-4DDA-A0BF-A616BEA9983AQ38451282-8B617793-D645-400D-935A-56B8F871971EQ38900947-0786C6A1-296B-4B45-8FDE-9F559B624FCBQ39307644-FBE2C30C-8091-4471-92B4-6904602A33E7Q41653522-0E32985D-FF69-4CA0-A507-B037AE564031Q47102500-C0E04F6C-E549-4142-8668-CAD1D178FC4EQ47117137-FAF7E5C0-F6C5-4AD1-AA1B-2619CD2B9C5AQ47828991-0FFA5089-FEED-42F5-B82B-8A09EB6B2645Q48293366-E65D6A8B-8992-466A-B2A1-494F9A76FCF3Q49805588-FCD81B5B-1D6A-4CE2-A1D0-2FBD4C0CDAF8Q53688957-BE96B714-89FD-4799-8E78-1BCBB3E76681
P2860
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.
@ast
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.
@en
type
label
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.
@ast
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.
@en
prefLabel
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.
@ast
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.
@en
P2093
P2860
P1476
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.
@en
P2093
James A Carson
James P White
John W Baynes
Mark Cairns
Melissa J Puppa
Shuichi Sato
P2860
P304
P356
10.1016/J.BBADIS.2011.08.010
P407
P577
2011-09-02T00:00:00Z